Retirement saving: why I’d buy these 2 FTSE 100 shares in an ISA or SIPP today

I think these two FTSE 100 (INDEXFTSE:UKX) shares could deliver improving outlooks after contrasting recent performances.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the FTSE 100 is made up of a wide range of companies that operate in a variety of sectors, its performance does not paint the full picture for its members.

As such, some FTSE 100 stocks have surged higher in recent months. By contrast, others have become increasingly unpopular among investors.

Here are two large-cap shares that have contrasting recent performances. While the reasons for buying them may be very different, both companies could deliver improving returns that help you to build a nest egg for retirement.

Smith & Nephew

Medical devices company Smith & Nephew (LSE: SN) has enjoyed a high level of growth over the last year. Its share price has gained over 40% at a time when the prospects for the FTSE 100 have become increasingly uncertain.

Looking ahead, the company may offer further capital growth potential. Its relatively low correlation with the wider economy may mean that it is less impacted by the prospect of a slowdown in the global GDP growth rate. This may lead to improving investor sentiment, with increasingly risk-averse investors likely to pivot towards companies that offer defensive credentials.

Smith & Nephew also offers long-term earnings growth potential. Demand for its products is likely to increase due to demographic changes, with an ageing world population that is also increasing in size potentially leading to rising sales.

Following its recent share price rise, the company trades on a price-to-earnings (P/E) ratio of around 25. This may suggest that it is overvalued. However, with its defensive characteristics and its upbeat financial growth prospects, it could continue to outperform the FTSE 100 over the long run.

BT

Unlike Smith & Nephew, BT (LSE: BT.A) has experienced a hugely challenging period in recent months. The company’s shares have declined by around 27%, with the business reporting a disappointing financial performance in its recent update.

For example, revenue and profit both declined in the first quarter of its current financial year. For the full year, BT is forecast to post a decline in net profit of 2%.

Although its near-term prospects may be somewhat downbeat, the company’s investment in improving the customer experience appears to be paying off. Its fixed line churn declined to 1.3% in the first quarter of the current year, while it has recorded 12 successive quarters of improving net promoter scores.

An improving customer experience could help to differentiate the business in what remains a highly competitive quad-play market. The investment being made by the business may also strengthen its long-term financial outlook, and could prompt a recovery.

Trading on a P/E ratio of just 6.2, BT appears to offer a wide margin of safety. Therefore, it could prove to be an appealing value investing opportunity that posts a recovery over the coming years.

Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »